Stroke Research Today is a free monthly online journal that collates and summarizes the latest research about Stroke, including details on treatment, recovery, rehabilitation, signs, symptoms.

Volume 4 (2007), Issue 12 (December)

1. Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients.
   Ophthalmology, 114(12): 2174-8. [Abstract] [Full-text]
2. Comparison of patients' assessments of the quality of stroke care with audit findings.
   Qual Saf Health Care, 16(6): 450-5. [Abstract] [Full-text]
3. Differences in the quality of primary medical care services by remoteness from urban settlements.
   Qual Saf Health Care, 16(6): 446-9. [Abstract] [Full-text]
4. Incidence of new stroke or new myocardial infarction or death at 39-month follow-up in patients with diabetes mellitus, hypertension or both with and without microalbuminuria.
   Cardiology, 109(1): 62-5. [Abstract] [Full-text]
5. Cardiovascular autonomic function in poststroke patients.
   Neurology, 69(24): 2249-55. [Abstract] [Full-text]
6. Physical health-related quality of life predicts stroke in the EPIC-Norfolk.
   Neurology, 69(24): 2243-8. [Abstract] [Full-text]
7. Identifying the carotid 'high risk' plaque: is it still a riddle wrapped up in an enigma?
   Eur J Vasc Endovasc Surg, 35(1): 2-8. [Abstract] [Full-text]
8. Epidemiology and causation of coronary heart disease and stroke in India.
   Heart, 94(1): 16-26. [Abstract] [Full-text]
9. Relationship between detectability of ischemic lesions by diffusion-weighted imaging and embolic sources in transient ischemic attacks.
   Eur Neurol, 59(1): 38-43. [Abstract] [Full-text]
10. The past and future of neuroprotection in cerebral ischaemic stroke.
    Eur Neurol, 59(1): 4-14. [Abstract] [Full-text]
11. Percutaneous balloon commissurotomy reduces incidence of ischemic cerebral stroke in patients with symptomatic rheumatic mitral stenosis.
    Int J Cardiol, 123(2): 189-90. [Abstract] [Full-text]
12. PFO and stroke: what are the data?
    Cardiol Rev, 16(1): 53-7. [Abstract] [Full-text]
13. Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study.
    Arterioscler Thromb Vasc Biol, 28(1): 142-7. [Abstract] [Full-text]
14. A review of therapeutic strategies for risk reduction of recurrent stroke.
    Prog Cardiovasc Dis, 50(4): 264-73. [Abstract] [Full-text]
15. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study.
    Stroke, 39(1): 100-4. [Abstract] [Full-text]
16. Association between apolipoprotein E genotype and carotid intima-media thickness may suggest a specific effect on large artery atherothrombotic stroke.
    Stroke, 39(1): 48-54. [Abstract] [Full-text]
17. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke.
    Stroke, 39(1): 69-74. [Abstract] [Full-text]
18. Rapid assessment of perfusion-diffusion mismatch.
    Stroke, 39(1): 75-81. [Abstract] [Full-text]
19. Impact of preexisting depression on length of stay and discharge destination among patients hospitalized for acute stroke: linked register-based study.
    Stroke, 39(1): 132-8. [Abstract] [Full-text]
20. Atorvastatin promotes presenilin-1 expression and Notch1 activity and increases neural progenitor cell proliferation after stroke.
    Stroke, 39(1): 220-6. [Abstract] [Full-text]
21. Stroke incidence and survival in the beginning of the 21st century in southern Sweden: comparisons with the late 20th century and projections into the future.
    Stroke, 39(1): 10-5. [Abstract] [Full-text]
22. Evidence of abnormal lower-limb torque coupling after stroke: an isometric study.
    Stroke, 39(1): 139-47. [Abstract] [Full-text]
23. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study.
    Stroke, 39(1): 30-5. [Abstract] [Full-text]
24. The 2007 Feinberg lecture: a new road map for neuroprotection.
    Stroke, 39(1): 242. [Abstract] [Full-text]
25. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke.
    Stroke, 39(1): 237-41. [Abstract] [Full-text]
26. Change in hemostatic markers after recombinant tissue-type plasminogen activator is not associated with the chance of recanalization.
    Stroke, 39(1): 234-6. [Abstract] [Full-text]
27. Evolution of neurological, neuropsychological and sleep-wake disturbances after paramedian thalamic stroke.
    Stroke, 39(1): 62-8. [Abstract] [Full-text]
28. Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians.
    Stroke, 39(1): 227-30. [Abstract] [Full-text]
29. Experimental model of lacunar infarction in the gyrencephalic brain of the miniature pig: neurological assessment and histological, immunohistochemical, and physiological evaluation of dynamic corticospinal tract deformation.
    Stroke, 39(1): 205-12. [Abstract] [Full-text]
30. Handicap and its determinants of change in stroke survivors: one-year follow-up study.
    Stroke, 39(1): 148-53. [Abstract] [Full-text]
31. Sex differences in acute stroke care in a statewide stroke registry.
    Stroke, 39(1): 24-9. [Abstract] [Full-text]
32. Time spent at home poststroke: "home-time" a meaningful and robust outcome measure for stroke trials.
    Stroke, 39(1): 231-3. [Abstract] [Full-text]
33. The cost of pediatric stroke care and rehabilitation.
    Stroke, 39(1): 161-5. [Abstract] [Full-text]
34. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).
    Stroke, 39(1): 87-99. [Abstract] [Full-text]
35. Sex differences in heritability of ischemic stroke: a systematic review and meta-analysis.
    Stroke, 39(1): 16-23. [Abstract] [Full-text]
36. Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study.
    Stroke, 39(1): 36-41. [Abstract] [Full-text]
37. A pilot study of randomized clinical controlled trial of gait training in subacute stroke patients with partial body-weight support electromechanical gait trainer and functional electrical stimulation: six-month follow-up.
    Stroke, 39(1): 154-60. [Abstract] [Full-text]
38. Functional significance of ipsilesional motor deficits after unilateral stroke.
    Arch Phys Med Rehabil, 89(1): 62-8. [Abstract] [Full-text]
39. Effect of botulinum toxin injection in the rectus femoris on stiff-knee gait in people with stroke: a prospective observational study.
    Arch Phys Med Rehabil, 89(1): 56-61. [Abstract] [Full-text]
40. Team training and stroke rehabilitation outcomes: a cluster randomized trial.
    Arch Phys Med Rehabil, 89(1): 10-5. [Abstract] [Full-text]
41. Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study.
    Clin Pharmacol Ther, 83(1): 52-60. [Abstract] [Full-text]

© 2004-2008 Stroke Research Today. All Rights Reserved.